Skip to content

Clinical trials

Scleroderma, Systemic trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: Austria Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20112
20141
20151
20191
20222
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Actelion2
Medical University of Graz2
AstraZeneca1
Heidelberg University1
Medical University Innsbruck1
Medical University of Vienna1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic11
Hypertension, Pulmonary3
Lung Diseases, Interstitial2
Pulmonary Arterial Hypertension2
Autoimmune Diseases1
Connective Tissue Diseases1
Familial Primary Pulmonary Hypertension1
Immune System Diseases1
Scleroderma, Diffuse1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.